A Better Tomorrow with HanAll

Innovative Therapeutics to Address Unmet Medical Needs of Patients

Developing Innovations for Healthier,
Longer lives for Patients

Developing Innovations for Healthier,
Longer lives for Patients

Committed to Pioneering Next
Generation Technology

Our company pledges to make meaningful contributions to patients by
improving current medical practices. We believe in science, take risks for
innovations, learn from mistakes, and humbly serve the patients.
HanAll
News
Latest News
NEWS

HanAll Biopharma Reports Second Quarter 2023 Financial Resul..

- Sales recorded KRW 41.4 billion, a 58 percent increase from the same period i..

2023.07.26
NEWS

HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vi..

- HanAll Biopharma and Daewoong Pharmaceutical have co-invested in Vincere Biosc..

2023.06.12
NEWS

HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-D..

- HanAll Biopharma and Daewoong Pharmaceutical will co-develop NurrOn Pharmaceut..

2023.05.25
NEWS

HanAll Biopharma, Conclusion of Joint Development Contract f..

HanAll Biopharma and Daewoong Pharmaceutical have announced that they have conc..

2023.05.24
NEWS

HanAll Biopharma Announces Results from Phase III randomized..

- Tanfanercept did not demonstrate statistical significance in either of the pri..

2023.05.19
NEWS

HanAll Biopharma Reports First Quarter 2023 Results and Prov..

-​Financial results for the first quarter ended with revenue of KRW 28.8 billion..

2023.04.28
NEWS

HanAll Biopharma Assigns Su-jin Park as Co-CEO to Drive Next..

- Su-jin Park joins HanAll Biopharma in a shared leadership role to strengthen p..

2023.03.29
NEWS

HanAll Biopharma Opens Applications for the 2023 Pharmaceuti..

- Applications for physicians trained in Indonesia now open until April 15, 2023..

2023.03.15
pipeline
HanAll is primed to develop innovative,
impactful therapies to address unmet medical needs
Tanfanercept
A novel, topical, anti-TNF alpha protein drug for the treatment
of inflammatory eye diseases including dry eye disease
VIEW MORE
Batoclimab
A novel, anti-FcRn antibody for the treatment
of autoimmune diseases
VIEW MORE
Immuno-oncology
Next-generation immune checkpoint inhibitor
VIEW MORE